325 related articles for article (PubMed ID: 32766253)
1. Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential.
Sun X; Wang M; Wang M; Yao L; Li X; Dong H; Li M; Sun T; Liu X; Liu Y; Xu Y
Front Cell Dev Biol; 2020; 8():651. PubMed ID: 32766253
[TBL] [Abstract][Full Text] [Related]
2. Role of monocarboxylate transporters in head and neck squamous cell carcinoma.
Chandel V; Maru S; Kumar A; Kumar A; Sharma A; Rathi B; Kumar D
Life Sci; 2021 Aug; 279():119709. PubMed ID: 34102188
[TBL] [Abstract][Full Text] [Related]
3. Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
Singh M; Afonso J; Sharma D; Gupta R; Kumar V; Rani R; Baltazar F; Kumar V
Semin Cancer Biol; 2023 May; 90():1-14. PubMed ID: 36706846
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate transporters in cancer.
Payen VL; Mina E; Van Hée VF; Porporato PE; Sonveaux P
Mol Metab; 2020 Mar; 33():48-66. PubMed ID: 31395464
[TBL] [Abstract][Full Text] [Related]
5. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells.
Dimmer KS; Friedrich B; Lang F; Deitmer JW; Bröer S
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):219-27. PubMed ID: 10926847
[TBL] [Abstract][Full Text] [Related]
6. Proton-coupled monocarboxylate transporters in cancer: From metabolic crosstalk, immunosuppression and anti-apoptosis to clinical applications.
Duan Q; Zhang S; Wang Y; Lu D; Sun Y; Wu Y
Front Cell Dev Biol; 2022; 10():1069555. PubMed ID: 36506099
[TBL] [Abstract][Full Text] [Related]
7. An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.
Park SJ; Smith CP; Wilbur RR; Cain CP; Kallu SR; Valasapalli S; Sahoo A; Guda MR; Tsung AJ; Velpula KK
Am J Cancer Res; 2018; 8(10):1967-1976. PubMed ID: 30416849
[TBL] [Abstract][Full Text] [Related]
8. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation.
Halestrap AP; Price NT
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):281-99. PubMed ID: 10510291
[TBL] [Abstract][Full Text] [Related]
9. Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment.
Liu T; Han S; Yao Y; Zhang G
Cancer Manag Res; 2023; 15():957-975. PubMed ID: 37693221
[TBL] [Abstract][Full Text] [Related]
10. Monocarboxylic acid transport.
Halestrap AP
Compr Physiol; 2013 Oct; 3(4):1611-43. PubMed ID: 24265240
[TBL] [Abstract][Full Text] [Related]
11. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
[TBL] [Abstract][Full Text] [Related]
12. The SLC16A family of monocarboxylate transporters (MCTs)--physiology and function in cellular metabolism, pH homeostasis, and fluid transport.
Adijanto J; Philp NJ
Curr Top Membr; 2012; 70():275-311. PubMed ID: 23177990
[TBL] [Abstract][Full Text] [Related]
13. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells.
Philp NJ; Wang D; Yoon H; Hjelmeland LM
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1716-21. PubMed ID: 12657613
[TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
Sheng G; Gao Y; Wu H; Liu Y; Yang Y
J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.
Kalyanaraman B; Cheng G; Hardy M
Front Oncol; 2022; 12():816504. PubMed ID: 35756631
[TBL] [Abstract][Full Text] [Related]
16. Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle.
Bonen A; Heynen M; Hatta H
Appl Physiol Nutr Metab; 2006 Feb; 31(1):31-9. PubMed ID: 16604139
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporters as targets and mediators in cancer therapy response.
Baltazar F; Pinheiro C; Morais-Santos F; Azevedo-Silva J; Queirós O; Preto A; Casal M
Histol Histopathol; 2014 Dec; 29(12):1511-24. PubMed ID: 24921258
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
[TBL] [Abstract][Full Text] [Related]
19. A systemic analysis of monocarboxylate transporters in ovarian cancer and possible therapeutic interventions.
Chatterjee P; Bhowmik D; Roy SS
Channels (Austin); 2023 Dec; 17(1):2273008. PubMed ID: 37934721
[TBL] [Abstract][Full Text] [Related]
20. Role of monocarboxylate transporters in drug delivery to the brain.
Vijay N; Morris ME
Curr Pharm Des; 2014; 20(10):1487-98. PubMed ID: 23789956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
